Rihab Nasr

4.7k total citations · 1 hit paper
98 papers, 3.7k citations indexed

About

Rihab Nasr is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Rihab Nasr has authored 98 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 29 papers in Cancer Research and 26 papers in Immunology. Recurrent topics in Rihab Nasr's work include T-cell and Retrovirus Studies (23 papers), MicroRNA in disease regulation (19 papers) and Retinoids in leukemia and cellular processes (17 papers). Rihab Nasr is often cited by papers focused on T-cell and Retrovirus Studies (23 papers), MicroRNA in disease regulation (19 papers) and Retinoids in leukemia and cellular processes (17 papers). Rihab Nasr collaborates with scholars based in Lebanon, France and United States. Rihab Nasr's co-authors include Hugues de Thé, Farah Nassar, Ali Bazarbachi, Olivier Hermine, Jun Zhu, Laurent Pérès, Valérie Lallemand-Breitenbach, Sally Temraz, Rabih Talhouk and Marwan El‐Sabban and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Rihab Nasr

98 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway

2008 588 citations Valérie Lallemand-Breitenbach, Rihab Nasr et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rihab Nasr Lebanon	33	2.3k	1.1k	705	654	612	98	3.7k
Kenji Ishitsuka Japan	33	2.3k 1.0×	1.5k 1.3×	429 0.6×	1.1k 1.7×	1.3k 2.1×	149	4.5k
Cynthia A. Pise-Masison United States	35	1.2k 0.5×	2.3k 2.1×	352 0.5×	92 0.1×	755 1.2×	81	3.8k
Valérie Lallemand-Breitenbach France	27	4.1k 1.8×	670 0.6×	375 0.5×	1.4k 2.1×	704 1.2×	37	4.7k
Maher Abdul‐Hay United States	13	1.0k 0.4×	396 0.4×	300 0.4×	1.0k 1.6×	564 0.9×	42	2.3k
Keith R. Marotti United States	19	1.3k 0.6×	702 0.6×	452 0.6×	200 0.3×	311 0.5×	36	2.8k
Hiro Wakasugi Japan	33	1.5k 0.6×	1.7k 1.5×	499 0.7×	180 0.3×	1.1k 1.7×	90	3.6k
Stephen M. Kelsey United Kingdom	27	1.3k 0.6×	543 0.5×	234 0.3×	759 1.2×	908 1.5×	75	2.9k
Xin Yuan China	30	2.3k 1.0×	569 0.5×	860 1.2×	91 0.1×	640 1.0×	75	4.3k
Sue Haupt Australia	30	1.9k 0.8×	282 0.3×	695 1.0×	179 0.3×	1.2k 1.9×	67	3.1k
John D. Haley United States	34	2.8k 1.2×	200 0.2×	771 1.1×	86 0.1×	1.9k 3.1×	95	4.8k

Countries citing papers authored by Rihab Nasr

Since Specialization

Citations

This map shows the geographic impact of Rihab Nasr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rihab Nasr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rihab Nasr more than expected).

Fields of papers citing papers by Rihab Nasr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rihab Nasr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rihab Nasr. The network helps show where Rihab Nasr may publish in the future.

Co-authorship network of co-authors of Rihab Nasr

This figure shows the co-authorship network connecting the top 25 collaborators of Rihab Nasr. A scholar is included among the top collaborators of Rihab Nasr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rihab Nasr. Rihab Nasr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rahal, Elias A., et al.. (2024). The molecular signature of BCR::ABL and BCR::ABL in a Drosophila melanogaster chronic myeloid leukemia model. iScience. 27(4). 109538–109538. 1 indexed citations

Nasr, Rihab, et al.. (2023). 71P MicroRNA (miRNA) a putative biomarker to better define the molecular apocrine breast cancer (MABC) subtype. ESMO Open. 8(1). 101294–101294. 1 indexed citations

Temraz, Sally, et al.. (2023). Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study. Frontiers in Nutrition. 10. 1110405–1110405. 2 indexed citations

Habel, Alex, Farah Nassar, Hanen Bouaziz, et al.. (2023). Mir-21 and Mir-125b as theranostic biomarkers for epithelial ovarian cancer in Tunisian women. African Health Sciences. 23(2). 256–64. 1 indexed citations

Temraz, Sally, Rihab Nasr, Deborah Mukherji, Firas Kreidieh, & Ali Shamseddine. (2022). Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma. Expert Review of Molecular Diagnostics. 22(5). 507–518. 11 indexed citations

Bouaoun, Liacine, Rihab Nasr, Arafat Tfayli, et al.. (2021). LINE-1 methylation mediates the inverse association between body mass index and breast cancer risk: A pilot study in the Lebanese population. Environmental Research. 197. 111094–111094. 4 indexed citations

Nassar, Farah, Arafat Tfayli, Rabih Talhouk, et al.. (2021). A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer. International Journal of Molecular Sciences. 22(11). 6121–6121. 41 indexed citations

Deen, Nataly Naser Al, Nadia A. Lanman, Shirisha Chittiboyina, et al.. (2021). A risk progression breast epithelial 3D culture model reveals Cx43/hsa_circ_0077755/miR-182 as a biomarker axis for heightened risk of breast cancer initiation. Scientific Reports. 11(1). 2626–2626. 10 indexed citations

Fadhil, Ibtihal, et al.. (2021). National cancer control plans across the Eastern Mediterranean region: challenges and opportunities to scale-up. The Lancet Oncology. 22(11). e517–e529. 17 indexed citations

10.

Zgheib, Nathalie K., Raafat Alameddine, Radwan Massoud, et al.. (2020). The role of candidate genetic polymorphisms in the interaction between voriconazole and cyclosporine in patients undergoing allogeneic hematopoietic cell transplantation: An explorative study. Current Research in Translational Medicine. 68(2). 51–58. 3 indexed citations

11.

Deen, Nataly Naser Al, Farah Nassar, Rihab Nasr, & Rabih Talhouk. (2019). Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability. Advances in experimental medicine and biology. 1152. 335–364. 12 indexed citations

12.

Nasr, Rihab, Vincent Cahais, Cyrille Cuenin, et al.. (2019). DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clinical Epigenetics. 11(1). 138–138. 23 indexed citations

13.

Temraz, Sally, Farah Nassar, Rihab Nasr, et al.. (2019). Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer. International Journal of Molecular Sciences. 20(17). 4155–4155. 97 indexed citations

14.

Nasr, Rihab, et al.. (2018). Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer Patients. International Journal of Molecular Sciences. 19(7). 1867–1867. 16 indexed citations

15.

Nassar, Farah, Rabih Talhouk, Nathalie K. Zgheib, et al.. (2017). microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis. Scientific Reports. 7(1). 16829–16829. 29 indexed citations

16.

Gargouri, Bochra, Rihab Nasr, Riadh Ben Mansour, et al.. (2011). Reactive Oxygen Species Production and Antioxidant Enzyme Expression after Epstein–Barr Virus Lytic Cycle Induction in Raji Cell Line. Biological Trace Element Research. 144(1-3). 1449–1457. 26 indexed citations

17.

Nasr, Rihab, Marie-Claude Guillemin, Omar Ferhi, et al.. (2008). Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nature Medicine. 14(12). 1333–1342. 267 indexed citations

18.

Vitoux, Dominique, Rihab Nasr, & Hugues de Thé. (2007). Acute promyelocytic leukemia: New issues on pathogenesis and treatment response. The International Journal of Biochemistry & Cell Biology. 39(6). 1063–1070. 20 indexed citations

19.

Bazarbachi, Ali, David Ghez, Yves Lepelletier, et al.. (2004). New therapeutic approaches for adult T-cell leukaemia. The Lancet Oncology. 5(11). 664–672. 95 indexed citations

20.

Darwiche, Nadine, Ghassan Dbaibo, Humam Kadara, et al.. (2003). N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells. Leukemia. 18(3). 607–615. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact